-- Scott Roberts
MONDAY, Aug. 16 (HealthDay News) -- The ella emergency
contraceptive has been approved by the U.S. Food and Drug
Administration. It's been available in Europe for more than a year
under the brand name ellaOne.
To be taken within five days of contraceptive failure or
unprotected intercourse, the drug is not meant to be used as a
routine contraceptive, the FDA said in news release. Among a class
of drugs called progesterone agonists/antagonists, it's intended to
inhibit or delay ovulation.
Ella's safety and effectiveness were demonstrated in studies
conducted in the United States, United Kingdom and Ireland, the
agency said. The most common side effects included headache,
nausea, abdominal pain, menstrual pain, fatigue and dizziness.
Women with known or suspected pregnancy or those who are
breast-feeding shouldn't use ella, the FDA said.
The drug is distributed by Watson Pharma Inc., based in
The FDA has more about
Please be aware that this information is provided to supplement the care provided by your physician. It is neither intended nor implied to be a substitute for professional medical advice. CALL YOUR HEALTHCARE PROVIDER IMMEDIATELY IF YOU THINK YOU MAY HAVE A MEDICAL EMERGENCY. Always seek the advice of your physician or other qualified health provider prior to starting any new treatment or with any questions you may have regarding a medical condition.
Copyright © EBSCO Publishing. All rights reserved.